Human FGF-19 Antibody, R&D Systems™

FGF-19

Western Blot 1 ug/mL, Blockade of Receptor-ligand Interaction, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

Monoclonal

Mouse

Human

O95750

9965

E. coli-derived recombinant human FGF-19 Phe27-Lys216 Accession # O95750

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human FGF-19 in direct ELISAs and Western blots. Shows approximately 10% cross-reactivity with recombinant human (rh) FGF-3 and rhFGF-5 and no cross-reactivity with rhFGF-4, rhFGF-6, rhFGF-7, rhFGF-9, rhFGF-10, rhFGF-13, rhFGF-16, rhFGF-17, rhFGF-18, rhFGF acidic, and rhFGF basic.

117611

Western Blot, Blockade of Receptor-ligand Interaction, ELISA

Unconjugated

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

FGF19, FGF-19, fibroblast growth factor 19

FGF19

IgG1

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.